4//SEC Filing
Lin Kenneth 4
Accession 0001641172-25-003091
CIK 0001815974other
Filed
Apr 6, 8:00 PM ET
Accepted
Apr 7, 9:41 PM ET
Size
7.5 KB
Accession
0001641172-25-003091
Insider Transaction Report
Form 4
Lin Kenneth
Director
Transactions
- Award
Stock Option (right to buy)
2025-04-04+25,000→ 25,000 totalExercise: $1.02Exp: 2035-04-03→ Common Stock (25,000 underlying) - Award
Stock Option (right to buy)
2025-04-04+4,964→ 4,964 totalExercise: $1.02Exp: 2035-04-03→ Common Stock (4,964 underlying)
Footnotes (1)
- [F1]The option vests on the earlier of April 4, 2026 or the date of the 2026 annual meeting of shareholders.
Documents
Issuer
Anebulo Pharmaceuticals, Inc.
CIK 0001815974
Entity typeother
Related Parties
1- filerCIK 0001770623
Filing Metadata
- Form type
- 4
- Filed
- Apr 6, 8:00 PM ET
- Accepted
- Apr 7, 9:41 PM ET
- Size
- 7.5 KB